Form D · Other
Bala Enzyme Inc.
Seal Beach, CA · CIK 0001902671
Offering snapshot reported Dec 11, 2025 · SEC filing
- Reported sold
- $921K Offering amount: $1.4M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 26, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 11, 2025 | Initial | $920,899 | No comparison | 6 | SEC filing |
| Jan 14, 2022 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-566480
Source: Form D, filed Dec 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arash Aftabi | Director, Executive |
| Farnoush Fadavi | Director, Executive |
| Jonathan Tse | Director |
Issuer details
Industry: Other (See others in industry)
Address:
13001 Seal Beach Boulevard, Suite 310
Seal Beach, CA, 90740
Seal Beach, CA, 90740